or Try an Advanced Search...

    Growth Hormone Therapy Stocks List

    Symbol Grade Name % Change
    NVO B Novo Nordisk A/S -0.86
    ASND D Ascendis Pharma A/S -1.37
    LUMO F Lumos Pharma, Inc. -3.42
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Growth Hormone Life Sciences Biopharmaceutical Biotechnology Diabetes Growth Hormone Deficiency Hormones Insulin Peptide Hormones Anti Diabetic Drugs Breakthrough Therapy Diabetes Care Disease Drug Therapies Endocrine System Genetic Diseases Glucagon Like Peptide 1 Haemophilia Hormone Therapy Hypertension

    Related ETFs - A few ETFs which own one or more of the above listed Growth Hormone Therapy stocks.

    Symbol Grade Name Weight
    EDEN B iShares MSCI Denmark Capped ETF 22.33
    MEDI D Harbor Health Care ETF 16.82
    PPH B Market Vectors Pharmaceutical ETF 9.49
    IGTR B Innovator Gradient Tactical Rotation Strategy ETF 8.56
    HRTS D Tema Cardiovascular and Metabolic ETF 7.71
    View all Growth Hormone Therapy ETFs...
    Compare ETFs
    Compare EDEN to PPH Compare PPH to HRTS Compare PPH to IGTR

        Growth Hormone Therapy Stocks Recent News

        Date Stock Title
        May 17 NVO 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
        May 17 NVO Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
        May 17 NVO 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
        May 17 NVO Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
        May 17 NVO Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
        May 16 NVO Dow Jones hits record milestone as US bets on faster rate cuts
        May 16 NVO Ozempic drives economic boom in Denmark as growth forecasts doubled
        May 16 NVO Denmark enjoys ‘Nokia moment’ as Ozempic flies off the shelves
        May 16 NVO Fire at Novo Nordisk Construction Site Gives Investors A Scare
        May 16 NVO Novo Nordisk falls on reports of fire at construction site (update)
        May 16 NVO 3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
        May 16 NVO Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
        May 16 NVO Lilly’s once-weekly insulin matches daily shots in late-stage tests
        May 15 NVO Novo Nordisk Weigh-Loss Drugs Could Bankrupt US Health Care, Senate Committee Report Says
        May 15 NVO No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms
        May 15 ASND FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
        May 15 NVO Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
        May 15 NVO Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
        May 15 ASND FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
        May 15 NVO If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today
        Related Industries: Biotechnology
        Related Stock Lists: Growth Hormone Life Sciences Biopharmaceutical Biotechnology Diabetes Growth Hormone Deficiency Hormones Insulin Peptide Hormones Anti Diabetic Drugs Breakthrough Therapy Diabetes Care Disease Drug Therapies Endocrine System Genetic Diseases Glucagon Like Peptide 1 Haemophilia Hormone Therapy Hypertension
        Growth Hormone Therapy

        Growth hormone therapy is a medical treatment that involves the use of growth hormones to treat a variety of conditions, including growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, chronic kidney disease, and other conditions. Growth hormone therapy is typically administered through injections, and it helps to stimulate the body’s natural production of growth hormones. This can help to improve physical growth, muscle mass, bone density, and overall health.

        Browse All Tags